VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease
Several symptomatic treatments for Parkinson's disease (PD) are currently available. Still, the challenge today is to find a therapy that might reduce degeneration and slow down disease progression. The identification of pathogenic mutations in familial Parkinsonism (fPD) associated to the mono...
Main Authors: | Simona Eleuteri, Alberto Albanese |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.01272/full |
Similar Items
-
VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
by: Gianni Cutillo, et al.
Published: (2020-11-01) -
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease
by: Erin T. Williams, et al.
Published: (2022-08-01) -
Commander Complex—A Multifaceted Operator in Intracellular Signaling and Cargo
by: Saara Laulumaa, et al.
Published: (2021-12-01) -
Multifaceted Roles of Retromer in EGFR Trafficking and Signaling Activation
by: Zhe Yang, et al.
Published: (2022-10-01) -
VPS35, the core component of the retromer complex, and Parkinson's disease
by: Ai‐Di Luo, et al.
Published: (2021-12-01)